Norinchukin Bank The Purchases 3,433 Shares of Colgate-Palmolive (NYSE:CL)

Norinchukin Bank The lifted its stake in shares of Colgate-Palmolive (NYSE:CL - Free Report) by 10.1% in the fourth quarter, according to the company in its most recent filing with the SEC. The fund owned 37,426 shares of the company's stock after buying an additional 3,433 shares during the quarter. Norinchukin Bank The's holdings in Colgate-Palmolive were worth $3,402,000 as of its most recent SEC filing.

A number of other institutional investors and hedge funds have also bought and sold shares of CL. Axxcess Wealth Management LLC increased its stake in shares of Colgate-Palmolive by 0.3% during the fourth quarter. Axxcess Wealth Management LLC now owns 38,786 shares of the company's stock worth $3,526,000 after purchasing an additional 117 shares during the period. Commonwealth Financial Services LLC boosted its position in shares of Colgate-Palmolive by 4.5% in the fourth quarter. Commonwealth Financial Services LLC now owns 2,716 shares of the company's stock valued at $247,000 after acquiring an additional 118 shares during the period. Wescott Financial Advisory Group LLC increased its position in Colgate-Palmolive by 3.5% during the fourth quarter. Wescott Financial Advisory Group LLC now owns 3,517 shares of the company's stock worth $320,000 after acquiring an additional 119 shares during the period. D Orazio & Associates Inc. boosted its holdings in Colgate-Palmolive by 4.2% in the 4th quarter. D Orazio & Associates Inc. now owns 2,982 shares of the company's stock valued at $271,000 after purchasing an additional 120 shares during the period. Finally, Lantz Financial LLC increased its holdings in shares of Colgate-Palmolive by 0.6% during the fourth quarter. Lantz Financial LLC now owns 20,140 shares of the company's stock worth $1,831,000 after purchasing an additional 122 shares during the period. Institutional investors and hedge funds own 80.41% of the company's stock.

Colgate-Palmolive Trading Down 1.3 %

CL traded down $1.23 during trading on Thursday, reaching $92.66. 11,290,917 shares of the stock traded hands, compared to its average volume of 4,646,598. The stock's 50-day moving average is $91.78 and its 200 day moving average is $92.31. Colgate-Palmolive has a 12 month low of $85.32 and a 12 month high of $109.30. The company has a quick ratio of 0.58, a current ratio of 0.92 and a debt-to-equity ratio of 13.40. The stock has a market capitalization of $75.16 billion, a PE ratio of 26.32, a P/E/G ratio of 4.20 and a beta of 0.40.

Colgate-Palmolive (NYSE:CL - Get Free Report) last issued its earnings results on Friday, January 31st. The company reported $0.91 earnings per share for the quarter, topping analysts' consensus estimates of $0.90 by $0.01. Colgate-Palmolive had a return on equity of 477.77% and a net margin of 14.38%. During the same period in the prior year, the company earned $0.87 earnings per share. Equities analysts anticipate that Colgate-Palmolive will post 3.75 earnings per share for the current year.

Colgate-Palmolive Increases Dividend

The business also recently declared a quarterly dividend, which will be paid on Thursday, May 15th. Shareholders of record on Thursday, April 17th will be issued a $0.52 dividend. This represents a $2.08 dividend on an annualized basis and a yield of 2.24%. This is a boost from Colgate-Palmolive's previous quarterly dividend of $0.50. The ex-dividend date is Thursday, April 17th. Colgate-Palmolive's dividend payout ratio (DPR) is presently 59.09%.

Colgate-Palmolive declared that its board has initiated a share buyback program on Thursday, March 20th that authorizes the company to buyback $5.00 billion in outstanding shares. This buyback authorization authorizes the company to reacquire up to 6.8% of its shares through open market purchases. Shares buyback programs are often a sign that the company's board of directors believes its shares are undervalued.

Wall Street Analysts Forecast Growth

Several equities analysts have weighed in on the company. Wells Fargo & Company lifted their price objective on Colgate-Palmolive from $83.00 to $88.00 and gave the company an "underweight" rating in a report on Wednesday, April 2nd. TD Cowen cut their price target on shares of Colgate-Palmolive from $110.00 to $100.00 and set a "buy" rating for the company in a report on Wednesday, January 8th. Royal Bank of Canada restated a "sector perform" rating and set a $101.00 price objective on shares of Colgate-Palmolive in a research report on Wednesday, January 29th. JPMorgan Chase & Co. reduced their target price on Colgate-Palmolive from $99.00 to $95.00 and set an "overweight" rating on the stock in a report on Friday, April 11th. Finally, Piper Sandler lowered their price target on Colgate-Palmolive from $108.00 to $107.00 and set an "overweight" rating for the company in a report on Monday, March 31st. One research analyst has rated the stock with a sell rating, ten have issued a hold rating and eleven have given a buy rating to the company's stock. According to MarketBeat, Colgate-Palmolive presently has a consensus rating of "Hold" and a consensus target price of $102.17.

About Colgate-Palmolive

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.